MedTrace Logo

Evaluation of Safety and Efficacy of Using Seraffix LTB - (Laser Tissue Bonding) System

NCT00521755 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2011-06-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of using Seraffix LTB system for soft tissue bonding.

Conditions

  • Dehiscence, Surgical Wound

Interventions

DEVICE

Seraffix LTB

laser soldering for soft tissue wounds

Sponsors & Collaborators

  • Seraffix

    lead INDUSTRY

Principal Investigators

  • Ossama Hatoum, Dr. · HaEmek Medical Center, Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-11-30
Completion
2010-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00521755 on ClinicalTrials.gov